Dr. Andrea Choe, CEO of Holoclara, was recently featured in Forbes’ first edition of the Prototype which features the...

Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergies and autoimmune disorders, today announced the completion...

Allergic and autoimmune diseases were first described in the early 1900s, which Holoclara said is the same time that...

This Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...